Literature DB >> 33856276

Coronavirus-19-Associated Retinopathy.

Christopher D Conrady1, Lisa J Faia2,3, Kevin S Gregg4, Rajesh C Rao5,6,7,8,9.   

Abstract

Background: To describe the first case of Coronavirus disease-2019 (COVID-19) vision loss from an acute outer retinopathy.
Methods: A retrospective case report from a tertiary referral center using multimodal retinal imaging and clinical examination findingsFindings: A 40-year-old female developed significant vision loss in her right eye shortly after developing fever and myalgias. She was found to be COVID positive, while her systemic laboratory evaluation was otherwise unremarkable. Multimodal imaging was consistent with a white-dot-like outer retinopathy and she was started on systemic prednisone. Within 10 days of starting steroids, her vision, symptoms, and outer retinal changes on multimodal imaging were improving.Interpretation: While exceedingly rare, COVID-19 can cause inflammatory-associated changes of the outer retina and significant vision loss.

Entities:  

Keywords:  COVID; coronavirus; outer retinopathy; vision loss

Mesh:

Year:  2021        PMID: 33856276      PMCID: PMC8487893          DOI: 10.1080/09273948.2021.1894456

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  13 in total

1.  Coronavirus Disease 2019-Associated Ocular Neuropathy With Panuveitis: A Case Report.

Authors:  Julie François; Axelle Semler Collery; George Hayek; Maxime Sot; Mohamed Zaidi; Louis Lhuillier; Jean Marc Perone
Journal:  JAMA Ophthalmol       Date:  2021-02-01       Impact factor: 7.389

Review 2.  The white dot syndromes.

Authors:  David A Quillen; Janet B Davis; Justin L Gottlieb; Barbara A Blodi; David G Callanan; Tom S Chang; Robert A Equi
Journal:  Am J Ophthalmol       Date:  2004-03       Impact factor: 5.258

3.  Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19).

Authors:  Alessandro Invernizzi; Marco Pellegrini; Dario Messenio; Matteo Cereda; Pietro Olivieri; Anna Maria Brambilla; Giovanni Staurenghi
Journal:  Ocul Immunol Inflamm       Date:  2020-09-25       Impact factor: 3.070

4.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study.

Authors:  Yanan Li; Man Li; Mengdie Wang; Yifan Zhou; Jiang Chang; Ying Xian; David Wang; Ling Mao; Huijuan Jin; Bo Hu
Journal:  Stroke Vasc Neurol       Date:  2020-07-02

5.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.

Authors:  Siwei Zhou; Edward C Jones-Lopez; Deepak J Soneji; Christina J Azevedo; Vivek R Patel
Journal:  J Neuroophthalmol       Date:  2020-09       Impact factor: 3.042

6.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.

Authors:  Andrew Clark; Mark Jit; Charlotte Warren-Gash; Bruce Guthrie; Harry H X Wang; Stewart W Mercer; Colin Sanderson; Martin McKee; Christopher Troeger; Kanyin L Ong; Francesco Checchi; Pablo Perel; Sarah Joseph; Hamish P Gibbs; Amitava Banerjee; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-06-15       Impact factor: 26.763

7.  Retinal findings in patients with COVID-19.

Authors:  Paula M Marinho; Allexya A A Marcos; André C Romano; Heloisa Nascimento; Rubens Belfort
Journal:  Lancet       Date:  2020-05-12       Impact factor: 79.321

8.  Microvascular Injury in the Brains of Patients with Covid-19.

Authors:  Myoung-Hwa Lee; Daniel P Perl; Govind Nair; Wenxue Li; Dragan Maric; Helen Murray; Stephen J Dodd; Alan P Koretsky; Jason A Watts; Vivian Cheung; Eliezer Masliah; Iren Horkayne-Szakaly; Robert Jones; Michelle N Stram; Joel Moncur; Marco Hefti; Rebecca D Folkerth; Avindra Nath
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

9.  Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection.

Authors:  Jonathan Virgo; Moin Mohamed
Journal:  Eye (Lond)       Date:  2020-07-03       Impact factor: 3.775

10.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China.

Authors:  Ping Wu; Fang Duan; Chunhua Luo; Qiang Liu; Xingguang Qu; Liang Liang; Kaili Wu
Journal:  JAMA Ophthalmol       Date:  2020-05-01       Impact factor: 7.389

View more
  4 in total

Review 1.  Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned.

Authors:  Jitender P Dubey
Journal:  Parasit Vectors       Date:  2021-05-19       Impact factor: 3.876

2.  Macular vessel density reduction in patients recovered from COVID-19: a longitudinal optical coherence tomography angiography study.

Authors:  Mojtaba Abrishami; Kiana Hassanpour; SeyedehMaryam Hosseini; Zahra Emamverdian; Mohammad-Reza Ansari-Astaneh; Ghodsieh Zamani; Bahareh Gharib; Majid Abrishami
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-12       Impact factor: 3.535

Review 3.  Use of Imaging Technology to Assess the Effect of COVID-19 on Retinal Tissues: A Systematic Review.

Authors:  Orlaith E McGrath; Tariq M Aslam
Journal:  Ophthalmol Ther       Date:  2022-04-29

4.  SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids.

Authors:  Yotam Menuchin-Lasowski; André Schreiber; Aarón Lecanda; Angeles Mecate-Zambrano; Linda Brunotte; Olympia E Psathaki; Stephan Ludwig; Thomas Rauen; Hans R Schöler
Journal:  Stem Cell Reports       Date:  2022-03-24       Impact factor: 7.294

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.